Not provided
Not provided
Not provided
Not provided
Withdrawn due to lack of recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, monocentric, randomized phase II study evaluating Low-Level Laser Therapy (LLLT) as a treatment for the pain due to grade 2 oral mucositis in patients with upper aero-digestive tract cancer treated by radiotherapy or chemoradiotherapy.
Patients with upper aero-digestive tract cancer receiving their first cervicofacial radiotherapy or chemoradiotherapy will be included in this study if they suffer from oral mucositis due to their treatment.
The study procedure will consist in 5 applications of the LLLT that will be performed at three days intervals for a maximum duration of 15 days.
Each patient will be followed until 3 days after the end of the study treatment, for a total duration of the study of 18 days.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Basic Oral Care + active LLLT (experimental arm) | Active Comparator |
| |
| Basic oral Care + inactive LLLT (control arm) | Placebo Comparator |
| |
| Basic Oral Care (control arm) | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Basic Oral Care + active LLLT | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of patients who didn't need a dose increase or introduction of new analgesics for mouth pain during the study compared to baseline | 16 days for each patient |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the oral mucositis pain intensity with Visual Analog Scale Scores | 16 days for each patient | |
| Quality of Life assessed by the Quality of Life Questionnaire specific to Head and Neck cancer (H&N35) | 16 days for each patient |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Universitaire du Cancer de Toulouse - Oncopole | Toulouse | France |
Not provided
Not provided
Not provided
Not provided
Not provided
| Basic oral Care + inactive LLLT | Other |
|
|
| Basic Oral Care | Other | Compliance with the Basic Oral Care only |
|
| Frequency of adverse events related to the LLLT using the National Cancer Institute Common Toxicity Criteria for Adverse Effects (NCI CTCAE) version 5.0 | 16 days for each patient |
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| D052016 | Mucositis |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided